average weekly weight loss on semaglutide results after 8 months Average Monthly Weight Loss on

What does the research show about Retatrutide

Many clinicians avoid the use of long acting sulfonylureas (glyburide) in these high-risk patients as glyburide has a higher risk of hypoglycemia compared to other sulfonylureas (39)

May not be appropriate when Certain medical histories, conditions, medications, or personal circumstances mean a GLP-1 or GIP therapy isnt safe or suitable or calls for extra caution

In the SURMOUNT-1 trial , participants without diabetes taking the highest dose (15 mg) experienced an average weight loss of 20.9% over 72 weeks

This data becomes invaluable when making dose adjustment decisions later